Skip to main content

Tryptophan Degradation During And After Gestation

  • Chapter
Developments in Tryptophan and Serotonin Metabolism

Abstract

In mice, activation of indoleamine-(2,3)-dioxygenase (IDO), an enzyme converting tryptophan to N-formyl-kynurenine, is required to achieve immunotolerance against the fetus and thus uncomplicated pregnancy. On the other hand, postpartum blues and depression appear to be related to reduced availability of tryptophan and serotonin. In healthy pregnant women with singleton pregnancies we consecutively analyzed kynurenine and tryptophan concentrations during pregnancy and postpartum. The kynurenine to tryptophan ratio (kyn/trp) was calculated as an estimate of IDO activity, and data were compared to concentrations of neopterin and 55kD soluble tumor necrosis factor receptor, two indicators of immune activation, and to alanineaminotransferase (ALT) levels. Increasing kynurenine and decreasing tryptophan concentrations were found during pregnancy. The data confirm earlier results and suggest significant degradation of tryptophan. In parallel, increasing concentrations of immune activation markers neopterin and sTNF-R55 were found, correlating significantly to the kyn/trp. The data point to an involvement of cytokine-induced IDO activation in the degradation of tryptophan observed during pregnancy. After pregnancy, sTNF-R55 and also neopterin concentrations declined, whereas tryptophan concentrations increased, indicating that immune activation and activation-induced tryptophan degradation has ceased. By contrast, still increased kynurenine concentrations and also increased kyn/trp suggest continuing turnover of tryptophan. Because also ALT was increased postpartum, abnormal activity of hepatic tryptophan pyrrolase and possibly other enzymes could be

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Y. Ozaki, M.P. Edelstein, D.S. Duch, Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon gamma, Proc. Nat!. Acad. Sci. USA 85, 1242–1246 (1988).

    Article  PubMed  CAS  Google Scholar 

  2. A. Freese, K.J. Swartz, M.J. During, J.B. Martin, Kynurenine metabolites of tryptophan: Implications for neurologic diseases, Neurology 40, 691–695 (1990).

    Article  PubMed  CAS  Google Scholar 

  3. D. Fuchs, A.A. Möller, E. Stöckle, G. Reibnegger, E.R. Werner, H. Wachter, Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and neurologic/ psychiatric symptoms, J. Acquir Immune Defic. Syndr. 3, 873–876 (1990).

    PubMed  CAS  Google Scholar 

  4. B. Widner, E.R. Werner, H. Schennach, H. Wachter, D Fuchs, Simultaneous measurement of serum tryptophan and kynurenine by HPLC, Clin. Chem. 43, 2424–2426 (1997).

    PubMed  CAS  Google Scholar 

  5. E.R. Pfefferkorn, Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan, Proc. Natl. Acad. Sci. U.S.A. 81, 908–912 (1984).

    Article  PubMed  CAS  Google Scholar 

  6. L.M.de la Maza, E.M. Peterson, Dependence of the in vitro antiproliferative activity of recombinant human gamma-interferon on the concentration of tryptophan in culture media, Cancer Res 48, 346–350 (1988).

    PubMed  Google Scholar 

  7. D.H. Munn, E. Shafizadeh, J.T. Attwood, I. Bondarev, A. Pashine, A.L. Mellor, Inhibition of T-cell proliferation by macrophage tryptophan catabolism, J. Exp. Med. 189, 1663–1672 (1999).

    Article  Google Scholar 

  8. A.L. Mellor, D.H. Munn, Tryptophan catabolism and T-cell tolerance: Immunosuppression by starvation?, Immunol.Today 20, 469–473 (1999).

    Article  PubMed  CAS  Google Scholar 

  9. D.H. Munn, E. Shafidazeh, J.T. Attwood, I. Bondarev, A. Pashine, A.L. Mellor, Prevention of allogeneic fetal rejection by tryptophan catabolism, Science 81, 1191–3 (1998).

    Article  Google Scholar 

  10. H. Schroecksnadel, G. Baier-Bitterlich, O. Dapunt, H. Wachter, D. Fuchs, Decreased Plasma Tryptophan in Pregnancy, Obstet. Gynecol. 88, 47–50 (1996).

    Article  Google Scholar 

  11. S.L. Handley, T.L. Dunn, G. Waldron, J.M. Baker, Tryptophan, cortisol and puerperal mood, Br. J. Psychiatry 136, 498–508 (1980)

    Article  CAS  Google Scholar 

  12. M. Maes, W. Ombelet, R. Verkerk, E. Bosmans, S. Scharpe, Effects of pregnancy and delivery on the availability of plasma tryptophan to the brain: relationships to delivery-induced immune activation and early post-partum anxiety and depression, Psycho!. Med. 31,847–858 (2001).

    CAS  Google Scholar 

  13. M. Maes, R. Verkerk, S. Bonaccorso, W. Ombelet, Depressive and anxiety symptoms in early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation, Life Sci. in press

    Google Scholar 

  14. P.R. Gard, S.L. Handley, A.D. Parsons, G. Waldron, A multivariate investigation of postpartum mood disturbance, Br. J. Psychiatry 148, 567–575 (1986).

    Article  CAS  Google Scholar 

  15. M.T. Abou-Saleh, R. Ghubash, L. Karim, M. Krymski, D.N. Anderson, The role of pterins and related factors in the biology of early postpartum depression, Eur. Neuropsychopharmacol. 9, 295–300 (1999).

    PubMed  CAS  Google Scholar 

  16. K. Schröcksnadel, B. Widner, A. Bergant, G. Neurauter, H. Schennach, H. Schröcksnadel, D. Fuchs, Longitudinal study of tryptophan degradation during and after gestation, Life Sci in press.

    Google Scholar 

  17. K.J. Arntzen, N.B. Liabakk, G. Jacobsen, T. Espevik, R. Austgulen, Soluble tumor necrosis factor receptor in serum and urine throughout normal pregnancy and at delivery, Am. J. Reprod. lmmunol. 34,163–169 (1995)

    CAS  Google Scholar 

  18. Y. Kudo, C.A. Boyd, The physiology of immune evasion during pregnancy; the critical role of placental tryptophan metabolism and transport, Pflugers Arch.-Eur. J. Physiol. 442, 639–641 (2001).

    CAS  Google Scholar 

  19. B. Widner, M. Ledochowski, D. Fuchs, Interferon gamma-induced tryptophan degradation: neuropsychiatrie and immunological consequences, Curr. Drug Metal). 1, 193–204 (2000).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Schröcksnadel, K., Widner, B., Neurauter, G., Fuchs, D., Schröcksnadel, H., Bergant, A. (2003). Tryptophan Degradation During And After Gestation. In: Allegri, G., Costa, C.V.L., Ragazzi, E., Steinhart, H., Varesio, L. (eds) Developments in Tryptophan and Serotonin Metabolism. Advances in Experimental Medicine and Biology, vol 527. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0135-0_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-0135-0_8

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4939-6

  • Online ISBN: 978-1-4615-0135-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics